Trexquant Investment LP Vertex Pharmaceuticals Inc Transaction History

Trexquant Investment LP

$6.33 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $789,287 - $863,610	1,936 Added 48.79%	5,904 $2.47 Million
Q4 2023 Feb 09, 2024	BUY	$343.0 - $410.68 $840,007 - $1.01 Million	2,449 Added 161.22%	3,968 $1.61 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $513,695 - $550,576	1,519 New	1,519 $528,000
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $13.6 Million - $15.5 Million	-48,044 Reduced 92.0%	4,176 $1.32 Million
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $6.58 Million - $7.41 Million	23,040 Added 78.96%	52,220 $15.1 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $7.99 Million - $8.92 Million	29,180 New	29,180 $8.45 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $2.67 Million - $3.37 Million	-15,061 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $2.73 Million - $3.06 Million	15,061 New	15,061 $2.73 Million
Q4 2020 Feb 11, 2021	SELL	$207.01 - $276.09 $3.87 Million - $5.17 Million	-18,712 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$255.65 - $303.1 $2.1 Million - $2.49 Million	8,206 Added 78.11%	18,712 $5.09 Million
Q2 2020 Aug 07, 2020	SELL	$225.48 - $295.8 $868,323 - $1.14 Million	-3,851 Reduced 26.82%	10,506 $3.05 Million
Q1 2020 May 08, 2020	SELL	$199.77 - $247.81 $2.62 Million - $3.25 Million	-13,134 Reduced 47.78%	14,357 $3.42 Million
Q4 2019 Feb 12, 2020	BUY	$166.71 - $223.91 $1.54 Million - $2.07 Million	9,262 Added 50.81%	27,491 $6.02 Million
Q3 2019 Nov 08, 2019	BUY	$166.23 - $187.09 $1.5 Million - $1.69 Million	9,027 Added 98.1%	18,229 $3.09 Million
Q2 2019 Aug 09, 2019	SELL	$164.61 - $190.37 $2.43 Million - $2.81 Million	-14,745 Reduced 61.57%	9,202 $1.69 Million
Q1 2019 May 13, 2019	BUY	$163.73 - $194.7 $3.92 Million - $4.66 Million	23,947 New	23,947 $4.41 Million
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $1.01 Million - $1.28 Million	-6,646 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$167.73 - $192.74 $3.81 Million - $4.38 Million	-22,733 Reduced 77.38%	6,646 $1.28 Million
Q2 2018 Aug 07, 2018	BUY	$145.72 - $169.96 $743,317 - $866,965	5,101 Added 21.01%	29,379 $4.99 Million
Q1 2018 May 03, 2018	BUY	$151.6 - $177.13 $3.68 Million - $4.3 Million	24,278 New	24,278 $3.96 Million
Q4 2017 Feb 09, 2018	SELL	$137.28 - $155.55 $777,553 - $881,035	-5,664 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$148.13 - $162.24 $839,008 - $918,927	5,664	5,664 $861,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account